Two recent Mayo Clinic studies offer a clearer picture of the rise of hepatocellular carcinoma (HCC), or liver cancer, which has tripled in the U.S. in the last three decades and has a 10 to 12 per cent five-year survival rate when detected in later stages. "The studies illuminate the importance of identifying people with risk factors in certain populations to help catch the disease in its early, treatable stages," said W. Ray Kim, M.D., a specialist in Gastroenterology and Hepatology and principal investigator of one study. Additional coverage: Indian Express, Advocate Hepatitis Blog, Hepatitis C Research and News, News Track India, BringMeTheNews

Times of India,  1/3/2012

Tags: Cancer, GI, Mayo Clinic Rochester